Open AccessAre There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?
Author(s) -
Philip G. Tibbo,
Kyle McKee,
Jeffrey H. Meyer,
Candice E. Crocker,
Katherine J. Aitchison,
Raymond W. Lam,
David Crockford
Publication year - 2020
Publication title -
the canadian journal of psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.68
H-Index - 117
eISSN - 1497-0015
pISSN - 0706-7437
DOI - 10.1177/0706743720945525
Subject(s) - position statement , psychiatry , mental illness , psychology , medicine , cannabinoid , mental health , family medicine , receptor
A position statement developed by the Canadian Psychiatric Association's (CPA) Research Committee and approved by the CPA's Board of Directors on May 13, 2020.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom